Nucleate Ignite Series – Educational series aimed to convey in-depth technical understanding of crucial roles in the biotech world
- co11ab
-
IP, drugdiscovery, Biotherapeutics, productdevelopment, regulatory, biotech
- 22 February 2024
The processes involved in creating a therapeutic program in biotech and pharma companies, and how it differs from academic science.
Cantabio Pharmaceuticals awarded grant from the Michael J. Fox Foundation to develop novel DJ-1 protein replacement therapy for the treatment of PD
- co11ab
-
biotech, drugdiscovery, cantabio, PD, parkinson
- 07 February 2024
Grant enables further development of Cantabio's innovative DJ-1 replacement therapy for the treatment of Parkinson's disease